nitrites has been researched along with Cardiac Remodeling, Ventricular in 18 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "enalapril alone to enhance vascular effects, increase LV contractility and prevent unfavorable remodeling and are consistent with vascular delivery of exogenous NO." | 5.32 | A nitric oxide-releasing derivative of enalapril, NCX 899, prevents progressive cardiac dysfunction and remodeling in hamsters with heart failure. ( Condorelli, G; Del Soldato, P; Dieterle, T; Gu, Y; Iwanaga, Y; Ongini, E; Peterson, KL; Presotto, C; Ross, J, 2004) |
| " Celiprolol (DOCA-CEL, n = 9, 10 mg/kg per day, subdepressor dose) or a vehicle (DOCA-V, n = 9) were given after induction of DOCA-salt hypertension for 5 weeks, and age-matched sham-operated rats (ShC, n = 9) served as a control group." | 3.71 | Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats. ( Kobayashi, N; Matsuoka, H; Mori, Y; Nakano, S; Shirataki, H; Tsubokou, Y, 2001) |
| " Besides these proteases, several investigations have demonstrated that reduced endogenous NO bioavailability is a central pathological event in hypertension." | 2.72 | Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension. ( Batista, RIM; Guimaraes, DA; Tanus-Santos, JE, 2021) |
| "enalapril alone to enhance vascular effects, increase LV contractility and prevent unfavorable remodeling and are consistent with vascular delivery of exogenous NO." | 1.32 | A nitric oxide-releasing derivative of enalapril, NCX 899, prevents progressive cardiac dysfunction and remodeling in hamsters with heart failure. ( Condorelli, G; Del Soldato, P; Dieterle, T; Gu, Y; Iwanaga, Y; Ongini, E; Peterson, KL; Presotto, C; Ross, J, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Guimaraes, DA | 1 |
| Batista, RIM | 1 |
| Tanus-Santos, JE | 1 |
| Rajani, SF | 1 |
| Faghihi, M | 1 |
| Imani, A | 1 |
| Gee, LC | 1 |
| Massimo, G | 1 |
| Lau, C | 1 |
| Primus, C | 1 |
| Fernandes, D | 1 |
| Chen, J | 1 |
| Rathod, KS | 1 |
| Hamers, AJP | 1 |
| Filomena, F | 1 |
| Nuredini, G | 1 |
| Ibrahim, AS | 1 |
| Khambata, RS | 1 |
| Gupta, AK | 1 |
| Moon, JC | 1 |
| Kapil, V | 1 |
| Ahluwalia, A | 1 |
| de Paula Vasconcelos, PC | 1 |
| Tirloni, CAS | 1 |
| Palozi, RAC | 1 |
| Leitão, MM | 1 |
| Carneiro, MTS | 1 |
| Schaedler, MI | 1 |
| Silva, AO | 1 |
| Souza, RIC | 1 |
| Salvador, MJ | 1 |
| Junior, AG | 1 |
| Kassuya, CAL | 1 |
| Bunbupha, S | 1 |
| Prachaney, P | 1 |
| Kukongviriyapan, U | 1 |
| Kukongviriyapan, V | 1 |
| Welbat, JU | 1 |
| Pakdeechote, P | 1 |
| Akcaboy, M | 1 |
| Kula, S | 1 |
| Göktas, T | 1 |
| Nazlıel, B | 1 |
| Terlemez, S | 1 |
| Celik, N | 1 |
| Celik, B | 1 |
| Buyan, N | 1 |
| Fadieienko, G | 1 |
| Gridniev, O | 1 |
| Cong, W | 1 |
| Niu, C | 1 |
| Lv, L | 1 |
| Ni, M | 1 |
| Ruan, D | 1 |
| Chi, L | 1 |
| Wang, Y | 2 |
| Yu, Q | 1 |
| Zhan, K | 1 |
| Xuan, Y | 1 |
| Tan, Y | 1 |
| Wei, T | 1 |
| Cai, L | 1 |
| Jin, L | 1 |
| Hu, J | 1 |
| Sharifi-Sanjani, M | 1 |
| Tofovic, SP | 1 |
| Filice, M | 1 |
| Amelio, D | 1 |
| Garofalo, F | 1 |
| David, S | 1 |
| Fucarino, A | 1 |
| Jensen, FB | 1 |
| Imbrogno, S | 1 |
| Cerra, MC | 1 |
| Agata, J | 3 |
| Chao, L | 3 |
| Chao, J | 3 |
| Iwanaga, Y | 1 |
| Gu, Y | 1 |
| Dieterle, T | 1 |
| Presotto, C | 1 |
| Del Soldato, P | 1 |
| Peterson, KL | 1 |
| Ongini, E | 1 |
| Condorelli, G | 1 |
| Ross, J | 1 |
| Ura, N | 1 |
| Yoshida, H | 2 |
| Shinshi, Y | 1 |
| Sasaki, H | 1 |
| Hyakkoku, M | 1 |
| Taniguchi, S | 1 |
| Shimamoto, K | 1 |
| Yao, YY | 1 |
| Yin, H | 1 |
| Shen, B | 1 |
| Yang, HY | 1 |
| Yang, SC | 1 |
| Chen, ST | 1 |
| Chen, JR | 1 |
| Higashi, T | 1 |
| Kobayashi, N | 2 |
| Hara, K | 1 |
| Shirataki, H | 2 |
| Matsuoka, H | 2 |
| Wolf, WC | 1 |
| Mori, Y | 1 |
| Nakano, S | 1 |
| Tsubokou, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Management of Renin-Angiotensin-Aldosterone System Blockade in Patients Admitted in Hospital With Confirmed Coronavirus Disease (COVID-19) Infection: The McGill RAAS-COVID-19 Randomized Controlled Trial[NCT04508985] | 46 participants (Actual) | Interventional | 2020-10-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nitrites and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension.
Topics: Animals; Antihypertensive Agents; Arteries; Heart; Humans; Hypertension; Hypertrophy, Left Ventricul | 2021 |
17 other studies available for nitrites and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Post-infarct morphine treatment reduces apoptosis and myofibroblast density in a rat model of cardiac ischemia-reperfusion.
Topics: Analgesics, Opioid; Animals; Antioxidants; Apoptosis; Coronary Vessels; Fibroblasts; Gelatinases; Li | 2020 |
Inorganic nitrate attenuates cardiac dysfunction: roles for xanthine oxidoreductase and nitric oxide.
Topics: Animals; Cardiomegaly; Case-Control Studies; Clinical Studies as Topic; Disease Models, Animal; Fibr | 2022 |
Diuretic herb Gomphrena celosioides Mart. (Amaranthaceae) promotes sustained arterial pressure reduction and protection from cardiac remodeling on rats with renovascular hypertension.
Topics: Aldosterone; Amaranthaceae; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Diuretic | 2018 |
Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Collagen; Disease Models, Anima | 2015 |
Effect of plasma NOx values on cardiac function in obese hypertensive and normotensive pediatric patients.
Topics: Adolescent; Biomarkers; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Echocardiograph | 2016 |
[FEATURES MANIFESTATIONS COMORBID CURRENTS OF GASTROESOPHAGEAL REFLUX DISEASE AND ARTERIAL HYPERTENSION DEPENDING ON THE DEGREE OF ARTERIAL HYPERTENSION].
Topics: Apelin; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Circadian Rhyth | 2015 |
Metallothionein Prevents Age-Associated Cardiomyopathy via Inhibiting NF-κB Pathway Activation and Associated Nitrative Damage to 2-OGD.
Topics: Aging; Animals; Apoptosis; Cardiomyopathies; Cytokines; Energy Metabolism; Enzyme Activation; Gene E | 2016 |
Nitrite Prevents Right Ventricular Failure and Remodeling Induced by Pulmonary Artery Banding.
Topics: Animals; Cells, Cultured; Heart Failure; Male; Mice; Mice, Inbred C57BL; Nitrites; Pulmonary Artery; | 2017 |
Angiotensin II dependent cardiac remodeling in the eel Anguilla anguilla involves the NOS/NO system.
Topics: Angiotensin II; Anguilla; Animals; Collagen; Heart; Heart Ventricles; HSP90 Heat-Shock Proteins; Mit | 2017 |
Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction.
Topics: Adenoviridae; Animals; Apoptosis; Cell Survival; Disease Models, Animal; Dobutamine; Gene Transfer T | 2002 |
A nitric oxide-releasing derivative of enalapril, NCX 899, prevents progressive cardiac dysfunction and remodeling in hamsters with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Cardiomyopathy, Dilated; Cricetinae; Cytos | 2004 |
Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Con | 2006 |
Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
Topics: Animals; Capillaries; Cardiac Output, Low; Cardiomegaly; Cells, Cultured; Collagen; Coronary Vessels | 2007 |
Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with L-NAME-induced hypertension.
Topics: Alanine Transaminase; Animals; Aorta; Aspartate Aminotransferases; Blood Pressure; Hydrolysis; Hyper | 2008 |
Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Bo | 2000 |
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
Topics: Adenoviridae; Animals; Blood Pressure; Blood Urea Nitrogen; Cardiomegaly; Cyclic GMP; Fibrosis; Gene | 2000 |
Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Blotting, Western; Celiprolol; Collagen; Desox | 2001 |